BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6833948)

  • 1. Induction of acute thrombocytopenia and infection of megakaryocytes by Rauscher murine leukemia virus reflect the genetic susceptibility to leukemogenesis.
    Grau GE; Puthavathana P; Izui S; Lambert PH
    J Exp Med; 1983 Mar; 157(3):1028-39. PubMed ID: 6833948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of the delayed phase of Rauscher virus-induced thrombocytopenia.
    Grau GE; Morrow D; Izui S; Lambert PH
    J Immunol; 1986 Jan; 136(2):686-91. PubMed ID: 3455704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F; Lilly F
    J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of antinuclear antibodies in mice infected with Rauscher leukemia virus.
    Varet B; Cannat A; Gisselbrecht S
    Cancer Res; 1977 Apr; 37(4):1115-8. PubMed ID: 300277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-21-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells.
    Lonai P; Katz E; Peled A; Haran-Ghera N
    Immunogenetics; 1981 Mar; 12(5-6):423-32. PubMed ID: 6260638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
    Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
    Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of H-2:H-7 congenic mice to study H-2-mediated resistance to Friend leukemia virus.
    Wettstein PJ; Blank KJ
    J Immunol; 1982 Jul; 129(1):358-61. PubMed ID: 7086137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of H-2 complex on susceptibility to infection by murine leukemia virus.
    Tucker HSt ; Weens J; Tsichlis P; Schwartz RS; Khiroya R; Donnelly J
    J Immunol; 1977 Apr; 118(4):1239-43. PubMed ID: 191531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
    Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
    J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of BPgp70, a fibroblast receptor for the envelope antigen of Rauscher murine leukemia virus.
    Landen B; Fox CF
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4988-92. PubMed ID: 6933542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-type hypersensitivity responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2379-88. PubMed ID: 2821177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of murine lymphocytes by Rauscher leukemia virus in vitro.
    Bubbers JE; Elder JH; Dixon FJ
    J Immunol; 1980 Jan; 124(1):388-94. PubMed ID: 7350233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral antigen expression on megakaryocytes and platelets: possible implications in the pathogenesis of thrombocytopenia.
    Grau GE; Lambert PH
    Prog Clin Biol Res; 1990; 356():275-86. PubMed ID: 2217444
    [No Abstract]   [Full Text] [Related]  

  • 18. Rauscher leukemia virus-induced tumor antigens: complete separation from gp70, p30 and H-2.
    Alaba O; Rogers MJ; Law LW
    Int J Cancer; 1979 Nov; 24(5):608-15. PubMed ID: 93583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilized TSTA and the major viral structural proteins, gp70 and p30, in the immune response to murine leukemias induced by Friend and Rauscher virus.
    Rogers MJ; Law LW; Appella E; Oroszlan S; Ting CC
    Int J Cancer; 1977 Aug; 20(2):303-8. PubMed ID: 892937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
    Kitagawa M; Kamisaku H; Aizawa S; Sado T
    Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.